# International Study of High-Risk Patients for Hepatocellular Carcinoma Using Liquid Biopsy

> **NCT05342350** · — · TERMINATED · sponsor: **Johns Hopkins University** · enrollment: 360 (actual)

## Conditions studied

- Liver Cancer
- Liver Cirrhosis
- Hepatocellular Carcinoma
- Early Stage Liver Cancer

## Interventions

- **OTHER:** GALAD Score

## Key facts

- **NCT ID:** NCT05342350
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2022-04-15
- **Primary completion:** 2025-06-07
- **Final completion:** 2025-06-07
- **Target enrollment:** 360 (ACTUAL)
- **Why stopped:** PI moving on from current institution
- **Last updated:** 2025-06-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05342350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05342350, "International Study of High-Risk Patients for Hepatocellular Carcinoma Using Liquid Biopsy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05342350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*